Clinical Study to Evaluate the Anti-Inflammatory and Beneficial Effects ofBeta Glucan foodsupplement on another Muscular Dystrophy other than DMD Patients
Not Applicable
- Conditions
- Health Condition 1: M638- Disorders of muscle in diseases classified elsewhere
- Registration Number
- CTRI/2022/05/042917
- Lead Sponsor
- MediNippon Health Care Private Limited MD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Subject who diagnosed with another muscular dystrophy other than Duchenne Muscular Dystrophy (DMD)
2. Male and Female subjects of age in between 3 years to 70 years
3. Subjects and legally authorized representative for vulnerable subjects must be willing to participate in the study and provide a written informed consent
4. Subject willing to and able to comply with the protocol
Exclusion Criteria
1. Subject participated in another clinical trial in the last 30 days.
2. Subjects and legally authorized representative for vulnerable subjects who has not given informed consent for this study
3. Subjects with history of multiple sclerosis
4. Subjects with history of any muscular atrophy
5. Pregnant and lactating females
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method